Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update

Affiliations

¹ Hofstra University, Hempstead, New York.
² City University of Hong Kong, Hong Kong, China.
³ Pfizer, New York, New York.
⁴ Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, Maryland.
⁵ Merck, Boston, Massachusetts.
⁶ New York Medical College, Valhalla, New York.

Comment

Lisa M DeTora et al. Ann Intern Med. 2023 Mar.

. 2023 Mar;176(3):eL220490.

doi: 10.7326/L22-0490.

¹ Hofstra University, Hempstead, New York.
² City University of Hong Kong, Hong Kong, China.
³ Pfizer, New York, New York.
⁴ Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, Maryland.
⁵ Merck, Boston, Massachusetts.
⁶ New York Medical College, Valhalla, New York.

No abstract available

Comment on

Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update.
DeTora LM, Toroser D, Sykes A, Vanderlinden C, Plunkett FJ, Lane T, Hanekamp E, Dormer L, DiBiasi F, Bridges D, Baltzer L, Citrome L. DeTora LM, et al. Ann Intern Med. 2022 Sep;175(9):1298-1304. doi: 10.7326/M22-1460. Epub 2022 Aug 30. Ann Intern Med. 2022. PMID: 36037471
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update.
Reinhard R. Reinhard R. Ann Intern Med. 2023 Mar;176(3):eL220488. doi: 10.7326/L22-0488. Ann Intern Med. 2023. PMID: 36940454 No abstract available.
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update.
Asif F. Asif F. Ann Intern Med. 2023 Mar;176(3):eL220489. doi: 10.7326/L22-0489. Ann Intern Med. 2023. PMID: 36940455 No abstract available.